These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6251443)

  • 21. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation.
    Spycher SE; Nick H; Rickli EE
    Eur J Biochem; 1986 Apr; 156(1):49-57. PubMed ID: 3007145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification of proenzymic and activated human C1s free ofC1r. Effect of calcium and ionic strength on activated C1s.
    Arlaud GJ; Reboul A; Meyer CM; Colomb MG
    Biochim Biophys Acta; 1977 Nov; 485(1):215-25. PubMed ID: 911862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of activation of the first component of complement (C1) by IgG oligomers.
    Tschopp J
    Mol Immunol; 1982 May; 19(5):651-7. PubMed ID: 6287242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosynthesis of the subcomponents C1q, C1r and C1s of the first component of complement (C1) by guinea pig hepatocyte primary cultures.
    Ramadori G; Heinz HP; Martin H; Meyer zum Büschenfelde KH; Loos M
    Eur J Immunol; 1986 Sep; 16(9):1137-41. PubMed ID: 3019707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domain structure, stability, and interactions of human complement C1s-: characterization of a derivative lacking most of the B chain.
    Busby TF; Ingham KC
    Biochemistry; 1988 Aug; 27(16):6127-35. PubMed ID: 2847785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.
    Reboul A; Bensa JC; Colomb MG
    Biochem J; 1986 Jan; 233(2):559-64. PubMed ID: 3006672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1 activation and dissociation in disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply to Mortensen et al.: The zymogen form of complement component C1.
    Almitairi JOM; Venkatraman Girija U; Furze CM; Simpson-Gray X; Badakshi F; Marshall JE; Schwaeble WJ; Mitchell DA; Moody PCE; Wallis R
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3867-E3868. PubMed ID: 29654143
    [No Abstract]   [Full Text] [Related]  

  • 32. Activation of the first component of complement.
    Schumaker VN; Zavodszky P; Poon PH
    Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
    [No Abstract]   [Full Text] [Related]  

  • 33. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
    Bensa JC; Reboul A; Colomb MG
    Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human complement serine proteases C1r and C1s and their proenzymes.
    Arlaud GJ; Thielens NM
    Methods Enzymol; 1993; 223():61-82. PubMed ID: 8271968
    [No Abstract]   [Full Text] [Related]  

  • 35. The dissociation properties of native C1.
    Ziccardi RJ; Tschopp J
    Biochem Biophys Res Commun; 1982 Jul; 107(2):618-23. PubMed ID: 6289835
    [No Abstract]   [Full Text] [Related]  

  • 36. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NH2-terminal calcium-binding domain of human complement C1s- mediates the interaction of C1r- with C1q.
    Busby TF; Ingham KC
    Biochemistry; 1990 May; 29(19):4613-8. PubMed ID: 2372546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
    J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the activation of the human C1r complement molecule.
    Bauer J; Valet G
    Mol Immunol; 1982 Mar; 19(3):487-95. PubMed ID: 6285181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and activation of C1: current concepts.
    Colomb MG; Arlaud GJ; Villiers CL
    Complement; 1984; 1(2):69-80. PubMed ID: 6100485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.